Company: BDRX
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001214659-25-007915
Chunk: 6

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-15
Form: 424B3
Chunk 6
---
 Date, the Holder shall
deliver or cause to be delivered to the Company such Holder’s aggregate exercise price for the exercised Warrant Shares, which shall
be made available for DVP settlement with the Company or its designee. Except as set forth herein, the terms of the Warrants, including
but not limited to the obligations to deliver the Warrant Shares, shall remain in effect as if the acceptance of this offer was a formal
exercise notice under the applicable Warrants. In addition, upon the receipt of the Ordinary Shares (in the form of American Depositary
Shares) pursuant to the Warrant Exercise, the Holder agrees to surrender the applicable Warrants exercised hereunder to the Company for
cancellation.

| 2 |

The Company acknowledges and
agrees that the obligations of the Holder under this letter agreement are several and not joint with the obligations of any other holder
warrants of the Company (each, an “”) under any other agreement related to the exercise of such warrants
(“”), and the Holder shall not be responsible in any way for the performance of the
obligations of any Other Holder or under any such Other Warrant Exercise Agreement. Nothing contained in this letter agreement, and no
action taken by the Holder pursuant hereto, shall be deemed to constitute the Holder and the Other Holders as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Holder and the Other Holders are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by this letter agreement and the Company acknowledges
that the Holder and the Other Holders are not acting in concert or as a group with respect to such obligations or the transactions contemplated
by this letter agreement or any Other Warrant Exercise Agreement. The Company and the Holder confirm that the Holder has independently
participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors. The Holder shall
be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this letter agreement,
and it shall not be necessary for any Other Holder to be joined as an additional party in any proceeding for such purpose.

Each party shall pay the fees
and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to
the negotiation, preparation, execution, delivery and performance of this letter agreement. The Company shall pay all transfer agent fees,
stamp